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The effort to model neural activity as a computation has its roots in
Santiago RamoÂn y Cajal's discovery late in the nineteenth century
that the brain was not a syncytium but, instead, a collection of
isolated cells. Each cell embodied a complex transformation of input
values which in turn passed on new values to other cells. The
research to model this transformation took on a life of its own,
distinct from physiology, with the discovery of the manifest power of
neural networks as classi®ers whose structure and weights could be
derived directly from the data. Any semblance to physical neurons
rapidly became symbolic. Progress in this area, however, was not
without its ®ts and starts. Although Minsky and Papert's in¯uential
book, Perceptrons, set lowered expectations in the 1960s for a
generation of neural network research (certainly a minor blip when
set beside their pioneering work in arti®cial intelligence and a few
other sundries such as Minsky's invention of confocal microscopy),
there was a resurgence in the 1980s when it was demonstrated that a
multilayered construction can give the classi®cation method
appreciable computational power. A good example of this power is
presented in a paper by Rubegni et al. (p. 471) that uses an arti®cial
neural network to fashion a melanoma detector.
The authors ®rst present a short summary of the impressive
results in melanoma detection that have been published based on
epiluminescence light microscopy (ELM). For the last 15 years,
various versions of this technique have used oil immersion to match
the optical properties of the device to those of the skin and thereby
improve the sharpness and contrast of the lesion. The improved
match of the refraction index between glass and skin both increases
the transmission of light into the skin and reduces the amount of
specularity that obscures subsurface detail (as with sunlight re¯ected
off of the surface of a lake). In addition, contrast is often enhanced
by some form of polarization ®ltering. The comparison between
ELM and surface photography is analogous to that between slide
and print ®lm. Re¯ectance images simply do not afford the same
dynamic range as when the epidermis and dermis are suffused with
light, allowing transillumination of pigmented regions. A number
of recent systems incorporate digital color cameras, an addition that
facilitates subsequent computer analysis. The instrument used in the
research presented here is the DBDermo-Mips, a system that was
developed at the University of Siena and provided for the
extraction of 48 lesion parameters from the images ± some grossly
apparent, and others not. Processing was performed with an image
resolution of 45 pixels per mm and with a 3CCD color camera (still
appreciably less than the equivalent resolution available with the
type of Kodachrome ®lm normally used in clinical imaging and the
same ®eld of view). A selection of 57 melanomas and 90 benign
pigmented lesions obtained in their clinic in Siena were used by the
authors to test the detector. Using the ten most signi®cant lesion
parameters, they constructed a classi®er that achieved a maximum
accuracy of 93% in detecting melanomas in the 147 lesion sample
set. Depending on the costs of false negatives and false positives, the
decision criterion can be altered to vary the obtained sensitivity and
speci®city (a sensitivity of 99% could be achieved but only with a
speci®city of 81%; a decrease in sensitivity to 93% allowed the
speci®city also to increase to 93%).
A strong point of neural networks is that once they are trained
and the weights are selected, their implementations can run
exceedingly fast (as distinct from the input ®lters that still often
require considerable image processing computations, hence less
than half of the signi®cant parameters were used). But, by far, the
greatest bene®t of this formulation is that, once designed, it is
completely objective and does not suffer from variations in the
training of the operator. For those not familiar with arti®cial neural
networks, a brief description of some of the techniques presented in
the paper is presented here as background. SLP: Single-Layer
Perceptrons are an elementary form of neural network. Weights are
applied to the inputs of each node and the results are summed. If
the total response exceeds a threshold the output is a 1 (the selected
property is detected); else, it is 0. SLPs are limited in that there are
certain types of relations among the inputs that they cannot
distinguish. ANN: Arti®cial Neural Networks are more powerful
classi®ers that have multiple layers of nodes: an input layer, one or
more hidden layers and an output layer (Fig 1). Similarly to SLPs,
inputs to each node are weighted, summed and transformed by an
output function. The weights are tuned by applying a set of lesions
whose classi®cation is known to the network and then using any
classi®cation errors to adjust the weights. Starting with the new set
of weights, the tuning is repeated. This process continues until a
satisfactory level of performance is achieved or no more
improvement can be induced. Leave one out: A statistical method
that allows the data used to train the network to also be used to
provide an estimate of how the current set of weights a new set of
lesions with the same characteristics as the test set. Stepwise feature
selection: When computational resources are limited and it is
desirable to optimize response time, this technique orders the
signi®cance of each of the input features and eliminates the one that
contributes the least until the desired compromise between speed
and performance is reached. ROC: The Receiver Operating
Characteristic is a graphical method of displaying the changes in
classifying malignant and benign lesions as the level of the network
output used to separate the two classes is changed. The graph plots
the probability of false positives (horizontal axis) versus the
probability of true positives (vertical axis). As the criterion goes
from being very strict to very lax, most ROC curves form arcs that
are vertical in the lower left of the plot (where many more true
positives are obtained at the cost of only a few false positives),
become less steep, and ®nally turn nearly horizontal in the upper
right (where many more false positives must be accepted to obtain
only a few more true positives). The more arced the curve, the
more discriminable is the task. A given sensitivity/speci®city pair
form a single point on an ROC curve.
In addition to these terms, two other issues deserve further
consideration: the development of input ®lters and the selection of
appropriate performance metrics. The choice of the input values
and the details of how they are operationalized are crucial to the
performance of the neural network and determine in large part how
well lesions can be classi®ed. In the extreme, one could simply take
all of the individual pixels as input values. Starting from such base
input, coming up with a way to ®nd meaningful properties from all
the differences observed in a set of lesions has proven very dif®cult
to achieve. Given the naturally occurring degree of variation and
noise, such detailed input almost universally leads to classi®cation
failure. Higher-level features (e.g., the gradient of dark regions
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from the center to the periphery of the lesion) must be individually
designed and selected to capture signi®cant qualities of the target.
Obtaining a good set of ®lters is often the most dif®cult part of the
task of building a classi®er.
Implicit in the search for algorithms with ever higher speci®city
and sensitivity is the assumption that melanoma detection is, in fact,
a highly discriminable task ± albeit a highly complex, multi-
dimensional one. The strength of the ANN technique comes from
the weighted combination of many properties, each of which may
be highly ambiguous when taken alone. A hint as to the upper
bound on performance can be obtained from the 3% of the
histological classi®cations that were in contention. Given that the
readings of the dermatopathologist are the gold standard in lesion
classi®cation, there will be a ceiling in the overlap and scoring
uncertainty of the lesion populations until markers more
unambiguous and unique to the disease are developed.
With such high performance available why, then, do only 25%
of dermatologists use any form of dermoscopy, and decidedly fewer
avail themselves of cutting edge digital analysis? It takes more than
good science to get a technique into the clinic. Is an automated
melanoma detector yet another expensive piece of equipment
squeezed into an already overcrowded exam room that requires
another time-consuming procedure to be squeezed into an already
overcrowded schedule? Is this something only for technophiles in
the laboratory or can a good business case be made? What is the
received bene®t over the established practice of when in doubt, cut
it out and let the pathologists sort it out? What is the value of the
reduction in delayed diagnosis or in unnecessary dis®gurement?
Answers to these questions are as important as the science in
actually getting the technology implemented.
In addition to sorting out these practical considerations,
clinicians are faced with a range of technological choices. Since
the early 1990s, almost every imaging laboratory with a new
technological hammer has tried to pound the melanoma nail. The
resulting multiplicity of currently available devices has led to a
degree of confusion and uncertainty as to what constitutes the best
available technique. Although the current work presents appreci-
able technical detail in the public record, this is not always the case.
Often, details suf®cient to actually recreate the experiment are not
available. Many instruments are currently offered, each with their
own proprietary transducer and processing algorithms. It is dif®cult
to sort out the wheat from the chaff.
In May, 1993, the committee created by the FCC to test
competing HDTV proposals itself created the Grand Alliance in
order to combine the four best of the 23 proposed, and proprietary,
ideas. Each individual proposal contained serious ¯aws and rather
than have a selection process among less than optimal alternatives, it
became clear that cooperation would produce the best result for the
public. Consideration should be given to creating a similar
mechanism to review the potential in the current array of
melanoma detection devices, an effort perhaps vetted by the
NCI. When the market is small (dermatology clinics) and the
instrumentation does not cost millions per unit, this form of
collaboration might be helpful in increasing user con®dence and
market penetration. An institutional resource that does not have a
vested interest in any particular technology could provide a
valuable service in testing and evaluation. Also, the potential to test
instruments under the same realistic conditions is valuable given
that even a moderately large set of lesions from a single clinic might
pose selection problems. It is certainly in the best interest of the
patient population to make to best instrumentation readily
accessible.
Technological advance does not end with ANNs. Other
detection technologies are on the horizon (e.g., confocal,
OCT). Dermoscopy in any of its forms is still a 2D
compression of a 3D lesion. A volumetric representation
might enrich the classi®cation by locating features relative to
functional structures such as the dermal±epidermal boundary.
The cameras used in dermoscopy usually have only three
overlapping broadband color ®lters. Expansion to spectro-
graphic analysis with more and narrower spectral ®lters also
offers promise. We lack even a basic standard as to what is
required in terms of pixels per mm on the skin or bits per pixel
for diagnostically suf®cient images. Do 45 pixels per mm
capture all the available, and necessary, information? Even
with the current uncertainties, one thing is clear ± when it
comes to imaging, dermatology is an orchard with much low
hanging fruit and technologies such as digital ELM deserve the
support required to bring them to the patient.
Figure 1. The basic organization of an Arti®cial Neural
Network. Inputs to each of the nodes in the left column are
weighted and summed and then an output transformation is applied
to the sum before it is passed on as input to hidden nodes of the
next layer (middle columns). The magnitude of the transformed
sum of an output node (the rightmost node) is used to assign the
classi®cation to the lesion represented by the current inputs.
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